Protein Biomarker Discovery in Non-depleted Serum by Spectral Library-Based Data-Independent Acquisition Mass Spectrometry.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 11 3 2019
pubmed: 11 3 2019
medline: 25 7 2019
Statut: ppublish

Résumé

In discovery proteomics experiments, tandem mass spectrometry and data-dependent acquisition (DDA) are classically used to identify and quantify peptides and proteins through database searching. This strategy suffers from known limitations such as under-sampling and lack of reproducibility of precursor ion selection in complex proteomics samples, leading to somewhat inconsistent analytical results across large datasets. Data-independent acquisition (DIA) based on fragmentation of all the precursors detected in predetermined isolation windows can potentially overcome this limitation. DIA promises reproducible peptide and protein quantification with deeper proteome coverage and fewer missing values than DDA strategies. This approach is particularly attractive in the field of clinical biomarker discovery, where large numbers of samples must be analyzed. Here, we describe a DIA workflow for non-depleted serum analysis including a straightforward approach through which to construct a dedicated spectral library, and indications on how to optimize chromatographic and mass spectrometry analytical methods to produce high-quality DIA data and results.

Identifiants

pubmed: 30852820
doi: 10.1007/978-1-4939-9164-8_9
doi:

Substances chimiques

Biomarkers 0
Blood Proteins 0
Peptides 0
Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

129-150

Auteurs

Alexandra Kraut (A)

Université Grenoble Alpes, CEA, Inserm, BGE U1038, Grenoble, France.

Mathilde Louwagie (M)

Université Grenoble Alpes, CEA, Inserm, BGE U1038, Grenoble, France.

Christophe Bruley (C)

Université Grenoble Alpes, CEA, Inserm, BGE U1038, Grenoble, France.

Christophe Masselon (C)

Université Grenoble Alpes, CEA, Inserm, BGE U1038, Grenoble, France.

Yohann Couté (Y)

Université Grenoble Alpes, CEA, Inserm, BGE U1038, Grenoble, France.

Virginie Brun (V)

Université Grenoble Alpes, CEA, Inserm, BGE U1038, Grenoble, France.

Anne-Marie Hesse (AM)

Université Grenoble Alpes, CEA, Inserm, BGE U1038, Grenoble, France. anne-marie.hesse@cea.fr.

Articles similaires

C-Reactive Protein Humans Biomarkers Inflammation
Humans Retrospective Studies Male Critical Illness Female
Humans Male Female Intensive Care Units COVID-19

Classifications MeSH